«Ectoderm

Below is an extended Ectoderm patents listing. Click here to return to the Ectoderm main in depth entry.

Patents :
US Patent No.	Title
7332281	Therapeutic targets in cancer
7358041	Antibodies to magmas and uses thereof
7358045	Methods for determining a predisposition to develop breast adenocarcinoma or breast inflammatory carcinoma
7361336	Methods of cancer therapy targeted against a cancer stem line
7361506	Differentiation of specialized dermal and epidermal cells into neuronal cells
7364900	Multi-lineage directed induction of bone marrow stromal cell differentiation
7368558	PRO357 nucleic acids
7371922	Nuclear transfer with porcine embryonic stem cells
7374760	Methods and compositions for nerve regeneration
7375184	PRO1382 polypeptides
7378274	Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses
7355002	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7354722	Modulators of Smurf and BMP/TGF.beta. signaling pathways
7351715	Unit dosage forms for the treatment of herpes simplex
7332336	Methods for inducing differentiation of pluripotent cells
7332589	Variants of alpha-fetoprotein coding and expression sequences
7332645	IL-21 as a regulator of immunoglobin production
7335643	Compositions of active Wnt protein
7338781	Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
7338934	Fibroblast growth factor-14
7344712	Urinary tract tissue graft compositions and methods for producing same
7344857	Neurogenin
7351529	Methods for detecting genetic mosaicisms using arrays
7351555	Mouse cytokine receptor Zcytor16
7378507	PRO217 polypeptides
7384784	Pax-encoding vector and use thereof
7413901	Method of forming vertebrate pancreas in vitro
7413903	Methods of regulating differentiation in stem cells
7413904	Human embryonic stem cells having genetic modifications
7414169	Therapeutic and diagnostic tools for impaired glucose tolerance conditions
7415358	Molecular toxicology modeling
7416849	HBM variants that modulate bone mass and lipid levels
7416885	Proliferated cell lines and uses thereof
7422736	Somatic pluripotent cells
7425448	Cardiomyocyte precursors from human embryonic stem cells
7426441	Methods for determining renal toxins
7413900	Immortalized fibroblasts
7413734	Treatment of retinitis pigmentosa with human umbilical cord cells
7412978	Augmentation and repair of vocal cord tissue defects
7390657	Method for generating primate trophoblasts
7390879	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7393686	Genetic demonstration of requirement for NKX6.1 and NKX2.2 in ventral neuron generation
7396533	Polypeptides and nucleic acids encoding same
7396908	OAF065alpha and OAF065beta polypeptides
7399633	Methods for immortalizing cells
7399834	Anti-PRO1558 antibodies
7402434	Splice choice antagonists as therapeutic agents
7408048	Mammalian grainyhead transcription factors
7410798	Culture system for rapid expansion of human embryonic stem cells
7427400	Methods of cancer diagnosis and therapy targeted against a cancer stem line

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.